NCT02279693

Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate Cancer

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 3 (actual)
• Sponsor: Centre Georges Francois Leclerc · Academic / Other
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates the dose received by the prostate with in vivo dosimetry when delivering image guided radiation therapy (IGRT) associated with intensity modulated radiation therapy (IMRT) for patients with localized prostate cancer using two repositioning techniques: fiduciary markers or soft tissues.

Detailed description

10 participants will receive a cone beam computed tomography (CBCT) repositioning, while the other 10 will receive a kV imaging of fiducial marker repositioning. The principal objective is to evaluate and compare the dose received by the prostate using two repositioning techniques.

Conditions

• Prostate Cancer

Interventions

Type	Name	Description
OTHER	CBCT	10 participants will receive a cone beam computed tomography (CBCT) repositioning
OTHER	fiducial marker (kV imaging)	10 participants will receive a kV imaging of fiducial marker repositioning.
RADIATION	IGRT Associated With IMRT

Timeline

• Start date: 2014-12-22
• Primary completion: 2014-12-22
• Completion: 2019-08-06
• First posted: 2014-10-31
• Last updated: 2024-02-14

Locations

1 site across 1 country: France